BACKGROUND: Congenital bicuspid aortic valves (BAVs) result from fusion of 2 valve cusps, resulting in left-noncoronary (L-N), right-left (R-L), and right-noncoronary (R-N) morphologic presentations. BAVs predispose to ascending thoracic aortic aneurysms (ATAAs). This study hypothesized that ATAAs with each BAV morphologic group possess unique signatures of matrix metalloproteinases (MMPs) and endogenous tissue inhibitors of metalloproteinases (TIMPs). METHODS: Ascending thoracic aortic aneurysm tissue from 46 patients with BAVs was examined for MMP/TIMP abundance, and global MMP activity was compared with normal aortic specimens (n=15). Proteolytic balance was calculated as the ratio of MMP abundance to a composite TIMP score. Results were stratified by valve morphologic group (L-N [n=6], R-L [n=31], and R-N [n=9]). RESULTS: The BAV specimens (p<0.05 versus normal aorta, 100%) displayed elevated global MMP activity (273%±63%), MMP-9 (263%±47%), and decreased MMP-7 (56%±10%), MMP-8 (58%±11%), TIMP-1 (63%±7%), and TIMP-4 (38%±3%). The R-L group showed increased global MMP activity (286%±89%) and MMP-9 (267%±55%) with reduced MMP-7 (45%±7%), MMP-8 (68%±15%), TIMP-1 (58%±7%), and TIMP-4 (35%±3%). The L-N group showed elevated global MMP activity (284%±71%) and decreased MMP-8 (37%±17%) and TIMP-4 (48%±14) activity. In the R-N group, MMP-7 (46%±13%) and MMP-8 (36%±17%) and TIMP-1 (59%±10%) and TIMP-4 (42%±5%) were decreased. The R-L group demonstrated an increased proteolytic balance for MMP-1, MMP-9, and MMP-12 relative to L-N and R-N. CONCLUSIONS: Each BAV morphologic group possesses a unique signature of MMPs and TIMPs. MMP/TIMP score ratios suggest that the R-L group may be more aggressive, justifying earlier surgical intervention.
BACKGROUND:Congenital bicuspid aortic valves (BAVs) result from fusion of 2 valve cusps, resulting in left-noncoronary (L-N), right-left (R-L), and right-noncoronary (R-N) morphologic presentations. BAVs predispose to ascending thoracic aortic aneurysms (ATAAs). This study hypothesized that ATAAs with each BAV morphologic group possess unique signatures of matrix metalloproteinases (MMPs) and endogenous tissue inhibitors of metalloproteinases (TIMPs). METHODS: Ascending thoracic aortic aneurysm tissue from 46 patients with BAVs was examined for MMP/TIMP abundance, and global MMP activity was compared with normal aortic specimens (n=15). Proteolytic balance was calculated as the ratio of MMP abundance to a composite TIMP score. Results were stratified by valve morphologic group (L-N [n=6], R-L [n=31], and R-N [n=9]). RESULTS: The BAV specimens (p<0.05 versus normal aorta, 100%) displayed elevated global MMP activity (273%±63%), MMP-9 (263%±47%), and decreased MMP-7 (56%±10%), MMP-8 (58%±11%), TIMP-1 (63%±7%), and TIMP-4 (38%±3%). The R-L group showed increased global MMP activity (286%±89%) and MMP-9 (267%±55%) with reduced MMP-7 (45%±7%), MMP-8 (68%±15%), TIMP-1 (58%±7%), and TIMP-4 (35%±3%). The L-N group showed elevated global MMP activity (284%±71%) and decreased MMP-8 (37%±17%) and TIMP-4 (48%±14) activity. In the R-N group, MMP-7 (46%±13%) and MMP-8 (36%±17%) and TIMP-1 (59%±10%) and TIMP-4 (42%±5%) were decreased. The R-L group demonstrated an increased proteolytic balance for MMP-1, MMP-9, and MMP-12 relative to L-N and R-N. CONCLUSIONS: Each BAV morphologic group possesses a unique signature of MMPs and TIMPs. MMP/TIMP score ratios suggest that the R-L group may be more aggressive, justifying earlier surgical intervention.
Authors: Scott A LeMaire; Xinwen Wang; Jonathan A Wilks; Stacey A Carter; Shixiang Wen; Taehee Won; Dominic Leonardelli; Gobind Anand; Lori D Conklin; Xing Li Wang; Robert W Thompson; Joseph S Coselli Journal: J Surg Res Date: 2005-01 Impact factor: 2.192
Authors: G Matthew Longo; Steven J Buda; Nicola Fiotta; Wanfen Xiong; Timothy Griener; Steven Shapiro; B Timothy Baxter Journal: Surgery Date: 2005-04 Impact factor: 3.982
Authors: John S Ikonomidis; Jeffery A Jones; John R Barbour; Robert E Stroud; Leslie L Clark; Brooke S Kaplan; Ahmed Zeeshan; Joseph E Bavaria; Joseph H Gorman; Francis G Spinale; Robert C Gorman Journal: J Thorac Cardiovasc Surg Date: 2007-02-26 Impact factor: 5.209
Authors: Alan C Braverman; Hasan Güven; Michael A Beardslee; Majesh Makan; Andrew M Kates; Marc R Moon Journal: Curr Probl Cardiol Date: 2005-09 Impact factor: 5.200
Authors: John R Barbour; Robert E Stroud; Abigail S Lowry; Leslie L Clark; Allyson M Leone; Jeffery A Jones; Francis G Spinale; John S Ikonomidis Journal: J Thorac Cardiovasc Surg Date: 2006-10 Impact factor: 5.209
Authors: Helena Kuivaniemi; Natzi Sakalihasan; Frank A Lederle; Gregory T Jones; Jean-Olivier Defraigne; Nicos Labropoulos; Victor Legrand; Jean-Baptiste Michel; Christoph Nienaber; Marc A Radermecker; John A Elefteriades Journal: Aorta (Stamford) Date: 2013-06-01
Authors: Ratnasari Padang; Paul G Bannon; Richmond Jeremy; David R Richmond; Christopher Semsarian; Michael Vallely; Michael Wilson; Tristan D Yan Journal: Ann Cardiothorac Surg Date: 2013-01
Authors: Rebekah M Ward; Jordan M Marsh; Jeffrey M Gossett; Mallikarjuna R Rettiganti; R Thomas Collins Journal: Pediatr Cardiol Date: 2017-11-29 Impact factor: 1.655
Authors: Julie A Phillippi; Jennifer C Hill; Marie Billaud; Benjamin R Green; Mary P Kotlarczyk; Thomas G Gleason Journal: Ann Thorac Surg Date: 2017-02-06 Impact factor: 4.330
Authors: Emilie Bollache; David G Guzzardi; Samaneh Sattari; Katherine E Olsen; Elena S Di Martino; S Chris Malaisrie; Pim van Ooij; Jeremy Collins; James Carr; Patrick M McCarthy; Michael Markl; Alex J Barker; Paul W M Fedak Journal: J Thorac Cardiovasc Surg Date: 2018-06-12 Impact factor: 5.209
Authors: Alkiviadis Tsamis; Julie A Phillippi; Ryan G Koch; Patrick G Chan; Jeffrey T Krawiec; Antonio D'Amore; Simon C Watkins; William R Wagner; David A Vorp; Thomas G Gleason Journal: J Thorac Cardiovasc Surg Date: 2016-02-13 Impact factor: 5.209